Furthermore, we demonstrate pro- and antidepressant effects of different genetic and/or pharmacological manipulations of the molecular clock, showing effects on glutamatergic-dependent homeostatic plasticity in the mPFC, implicating a direct causative role for mPFC clock dysfunction in depression and demonstrating the therapeutic potential of such clock modulations. The gene discussed is CLOCK; the disease is major depressive disorder.